MedPath

Dexpramipexole

Generic Name
Dexpramipexole
Drug Type
Small Molecule
Chemical Formula
C10H17N3S
CAS Number
104632-28-2
Unique Ingredient Identifier
WI638GUS96

Overview

Dexpramipexole is under investigation in clinical trial NCT01511029 (Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)).

Background

Dexpramipexole is under investigation in clinical trial NCT01511029 (Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 2
Active, not recruiting
Posted: 2024/08/01
Sponsor:
Areteia Therapeutics
Phase 3
Posted: 2024/04/29
Sponsor:
Areteia Therapeutics
Phase 3
Active, not recruiting
Posted: 2023/02/28
Sponsor:
Areteia Therapeutics

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath